Mirum Pharmaceuticals
MIRM
₹4,462
Share price
-0.66%
Change (1 day)
26.69%
Change (1 year)
Categories
P/S ratio for Mirum Pharmaceuticals (MIRM)
P/S ratio as of July 2025 (TTM): 6.73
According to Mirum Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 10.9. At the end of 2025 the company had a P/S ratio of 5.94.
P/S ratio history for Mirum Pharmaceuticals from 2019 to 2025
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2025 | 5.94 | 0.37% |
| 2024 | 5.92 | -19.79% |
| 2023 | 7.38 | -20.86% |
| 2022 | 9.33 | -63.46% |
| 2021 | 25.5 | |
| 2020 | N/A | |
| 2019 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |